1. Home
  2. FIZZ vs NAMS Comparison

FIZZ vs NAMS Comparison

Compare FIZZ & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Beverage Corp.

FIZZ

National Beverage Corp.

HOLD

Current Price

$31.31

Market Cap

3.3B

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$30.32

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIZZ
NAMS
Founded
1985
2019
Country
United States
Netherlands
Employees
N/A
100
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.7B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
FIZZ
NAMS
Price
$31.31
$30.32
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
1
8
Target Price
$35.00
$46.75
AVG Volume (30 Days)
655.9K
907.0K
Earning Date
03-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.96
N/A
Revenue
$1,180,552,000.00
N/A
Revenue This Year
$0.14
$17.96
Revenue Next Year
$3.33
$540.65
P/E Ratio
$15.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.01
$21.14
52 Week High
$47.47
$42.21

Technical Indicators

Market Signals
Indicator
FIZZ
NAMS
Relative Strength Index (RSI) 44.75 42.77
Support Level $30.66 $29.28
Resistance Level $35.84 $37.29
Average True Range (ATR) 0.99 1.78
MACD 0.04 -0.41
Stochastic Oscillator 35.30 10.96

Price Performance

Historical Comparison
FIZZ
NAMS

About FIZZ National Beverage Corp.

National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

Share on Social Networks: